118 related articles for article (PubMed ID: 24780059)
1. Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.
Paulson K; Serebrin A; Lambert P; Bergeron J; Everett J; Kew A; Jones D; Mahmud S; Meloche C; Sabloff M; Sharif I; Storring J; Turner D; Seftel MD
Br J Haematol; 2014 Sep; 166(5):660-6. PubMed ID: 24780059
[TBL] [Abstract][Full Text] [Related]
2. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
3. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
Micol JB; Raffoux E; Boissel N; Lengliné E; Canet E; Daniel MT; Labarthe Ad; Maarek O; Cassinat B; Adès L; Baruchel A; Degos L; Azoulay E; Dombret H
Eur J Cancer; 2014 Apr; 50(6):1159-68. PubMed ID: 24440088
[TBL] [Abstract][Full Text] [Related]
4. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
[TBL] [Abstract][Full Text] [Related]
5. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012.
Thuler LCS; Pombo-de-Oliveira MS
Ann Hematol; 2017 Mar; 96(3):355-362. PubMed ID: 27752823
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of acute promyelocytic leukemia in Italy. APL Collaborating Group.
Avvisati G; Mele A; Stazi MA; Vegna ML; Pasquini P; Mandelli F
Ann Oncol; 1991 Jun; 2(6):405-8. PubMed ID: 1768626
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of acute promyelocytic leukaemia.
Douer D
Best Pract Res Clin Haematol; 2003 Sep; 16(3):357-67. PubMed ID: 12935956
[TBL] [Abstract][Full Text] [Related]
8. Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.
Bally C; Fadlallah J; Leverger G; Bertrand Y; Robert A; Baruchel A; Guerci A; Recher C; Raffoux E; Thomas X; Leblanc T; Idres N; Cassinat B; Vey N; Chomienne C; Dombret H; Sanz M; Fenaux P; Adès L
J Clin Oncol; 2012 May; 30(14):1641-6. PubMed ID: 22473162
[TBL] [Abstract][Full Text] [Related]
9. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L
J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G
Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
[TBL] [Abstract][Full Text] [Related]
11. Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients.
Varghese C; Liu VY; Immanuel T; Chien N; Green T; Chan G; Theakston E; Kalev-Zylinska M
Hematology; 2021 Dec; 26(1):215-224. PubMed ID: 33594940
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
13. The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis.
Chen Z; Mai W; Li Z; Zhang H; Zheng Y; Hong S; Yang W; Xiao W; Chen Z; Wang S
Leuk Lymphoma; 2019 Dec; 60(14):3470-3481. PubMed ID: 31305195
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group.
Pulsoni A; Stazi A; Cotichini R; Allione B; Cerri R; Di Bona E; Nosari AM; Pagano L; Recchia A; Ribersani M; Rocchi L; Veneri D; Visani G; Mandelli F; Mele A
Eur J Haematol; 1998 Nov; 61(5):327-32. PubMed ID: 9855248
[TBL] [Abstract][Full Text] [Related]
15. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
Elliott MA; Letendre L; Tefferi A; Hogan WJ; Hook C; Kaufmann SH; Pruthi RK; Pardanani A; Begna KH; Ashrani AA; Wolanskyj AP; Al-Kali A; Litzow MR
Eur J Haematol; 2012 Mar; 88(3):237-43. PubMed ID: 22023492
[TBL] [Abstract][Full Text] [Related]
17. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
[TBL] [Abstract][Full Text] [Related]
18. Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013.
Lehmann S; Deneberg S; Antunovic P; Rangert-Derolf Å; Garelius H; Lazarevic V; Myhr-Eriksson K; Möllgård L; Uggla B; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2017 Jun; 31(6):1457-1459. PubMed ID: 28232742
[No Abstract] [Full Text] [Related]
19. Acute promyelocytic leukemia-associated thrombosis.
Chang H; Kuo MC; Shih LY; Wu JH; Lin TL; Dunn P; Tang TC; Hung YS; Wang PN
Acta Haematol; 2013; 130(1):1-6. PubMed ID: 23343825
[TBL] [Abstract][Full Text] [Related]
20. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
